info icon

Malignant neoplasm of other and ill-defined sites, including Hilmo

C3_OTHER_OR_ILLDEFINED_SITES_WIDE

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 C76
  • Hospital discharge: ICD-9 195
  • Hospital discharge: ICD-8 195
  • Cause of death: ICD-10 C76
  • Cause of death: ICD-9 195
  • Cause of death: ICD-8 195
  • Cancer registry: Topography ICD-O-3 C76
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

721

4. Check minimum number of events

None

721

5. Include endpoints

None

721

6. Filter based on genotype QC (FinnGen only)

625

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 625 288 337
Unadjusted period prevalence (%) 0.13 0.10 0.15
Median age at first event (years) 69.17 67.54 70.56

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
650
Matched controls
6500
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
86.5
307.7
199
33
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
262.9
234
*
130
Kela drug reimbursment
Malignant tumour
+∞
227.9
205
*
A03FA01
ATC
metoclopramide; systemic, rectal
11.7
213.7
301
447
Z51.5
ICD-10 Finland
Palliative care
16.1
193.4
187
159
A04AA01
ATC
ondansetron; systemic, rectal
23.8
160.5
121
62
JN4BD
NOMESCO Finland
Extensive body CT
14.1
135.6
136
120
JN4AD
NOMESCO Finland
Body CT examination
10.3
115.9
146
178
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
+∞
111.8
104
*
N02AA05
ATC
oxycodone; systemic
6.1
107.8
266
664
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1122.3
101.0
96
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
99.6
93
*
R18
ICD-10 Finland
Ascites
23.0
93.8
70
34
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.0
90.8
88
72
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
86.4
81
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
15.2
78.7
72
53
C76.0
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Head, face and neck
+∞
77.7
73
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
793.5
73.7
71
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
374.9
68.9
68
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
24.0
64.7
47
21
C76.3
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Pelvis
+∞
63.6
60
*
L03AA13
ATC
pegfilgrastim; parenteral
338.5
61.5
61
*
C76.1
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Thorax
+∞
60.4
57
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
58.2
55
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
55.0
52
*
L01BC06
ATC
capecitabine; oral
+∞
55.0
52
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
203.9
54.9
56
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
53.9
51
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
53.9
51
*
WW500
NOMESCO Finland
Blood transfusion
11.5
49.4
53
50
JN4CD
NOMESCO Finland
Very extensive body CT
14.9
46.3
42
30
L03AA02
ATC
filgrastim; parenteral
+∞
45.3
43
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.7
44.7
47
43
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
241.3
44.5
45
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.9
43.7
72
116
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
123.5
43.3
46
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
43.2
41
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
43.2
41
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
42.1
40
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
+∞
41.1
39
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
41.1
39
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
40.0
38
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.9
39.6
47
51
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
38.9
37
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.1
38.4
228
968
B01AB10
ATC
tinzaparin; parenteral
4.6
38.3
102
254
115
Kela drug reimbursment
Breast cancer
+∞
37.9
36
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
36.8
35
*
WF002
NOMESCO Finland
Radical radiotherapy
134.3
36.1
38
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
35.8
34
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.0
35.1
66
121
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
34.7
33
*
ZX120
NOMESCO Finland
Intravenous
4.7
33.9
85
201
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
33.6
32
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
32.6
31
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
32.6
31
*
C76.7
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Other ill-defined sites
+∞
31.5
30
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
73.7
31.2
35
5
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
10.0
30.9
36
38
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
30.5
29
*
116
Kela drug reimbursment
Prostate cancer
+∞
30.5
29
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
10.8
30.0
33
32
JAL30
NOMESCO Finland
Omentectomy
39.1
29.6
37
10
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
29.4
28
*
L02BG04
ATC
letrozole; oral
46.1
29.0
35
8
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
28.3
27
*
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
28.3
27
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
28.3
27
*
A79
ICPC
Malignancy NOS
293.5
28.0
28
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
7.2
27.0
41
60
KCD02
NOMESCO Finland
Transurethral resection of bladder
43.4
27.0
33
8
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.9
26.6
37
49
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
26.2
25
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
26.2
25
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
26.2
25
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
26.2
25
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
26.2
25
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
62.8
26.2
30
5
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
25.8
62
141
JAH00
NOMESCO Finland
Laparotomy
6.8
25.5
41
64
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
+∞
25.2
24
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.4
25.2
51
100
JAH01
NOMESCO Finland
Laparoscopy
6.4
24.8
42
69
A04AD12
ATC
aprepitant; systemic
+∞
24.1
23
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
24.1
23
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
9.7
23.7
28
30
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
6.0
23.6
43
76
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
23.6
105
368
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
23.1
22
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
22.0
21
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
22.0
21
*
8000/3-C76.2
ICD-O-3
Neoplasm, malignant of abdomen, NOS
+∞
22.0
21
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
22.0
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
83.0
21.8
24
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
21.8
114
438
HA1AA
NOMESCO Finland
X-ray mammography
5.7
21.0
40
74
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
20.9
102
376
JEA00
NOMESCO Finland
Appendectomy
4.6
20.7
51
118
R4190
NOMESCO Finland
Nutritional therapy
7.2
20.5
31
45
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
5.4
20.3
41
80
C76.5
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Lower limb
+∞
19.9
19
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
19.9
19
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
206.0
19.7
20
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
206.0
19.7
20
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.9
19.4
44
95
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
18.8
18
*
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
18.8
18
*
B01AB05
ATC
enoxaparin; parenteral
2.2
18.8
220
1225
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
17.8
17
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
17.8
17
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
17.8
17
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
17.8
17
*
L02BA01
ATC
tamoxifen; oral
184.8
17.6
18
*
WZC30
NOMESCO Finland
Teaching
2.7
17.0
99
400
A06AH03
ATC
naloxegol; oral
22.6
17.0
24
11
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
65.1
16.8
19
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
16.7
16
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
16.7
16
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
16.7
16
*
WX402
NOMESCO Finland
General anaesthesia
2.5
16.4
122
556
L02AE02
ATC
leuprorelin; implant, parenteral
30.9
16.2
21
7
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
15.7
15
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
15.7
15
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
15.7
15
*
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
+∞
15.7
15
*
L02BB03
ATC
bicalutamide; oral
+∞
15.7
15
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
15.7
15
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
163.8
15.5
16
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
39.1
15.5
19
5
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
21.6
14.7
21
10
HAC20
NOMESCO Finland
Total mastectomy
+∞
14.6
14
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
14.5
88
362
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
153.3
14.5
15
*
A98
ICPC
Health maint/preventive medicine
0.5
14.0
408
4979
LCD00
NOMESCO Finland
Hysterectomy
4.2
14.0
38
95
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
11.8
13.9
25
22
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
13.6
13
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
13.6
13
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
13.6
13
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
13.6
13
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
13.6
13
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
9.6
12.6
25
27
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
12.5
12
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
12.5
12
*
A04AA03
ATC
tropisetron; systemic
+∞
12.5
12
*
1XC07, ,
NOMESCO Finland
+∞
12.5
12
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
132.5
12.5
13
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
5.5
12.4
24
45
ZZR00
NOMESCO Finland
Flap of skin
38.3
12.2
15
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
38.3
12.2
15
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
27.3
12.1
16
6
HAB40
NOMESCO Finland
Wedge excision of mammary gland
21.8
12.1
17
8
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
12.1
147
813
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.0
12.0
55
195
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.5
11.9
23
43
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.7
11.7
68
273
N02AX02
ATC
tramadol; systemic, rectal
1.8
11.6
276
1893
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
11.5
11
*
8140/3-C76.2
ICD-O-3
Adenocarcinoma, NOS, of abdomen, NOS
+∞
11.5
11
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
11.5
11
*
8070/3-C80.9
ICD-O-3
Squamous cell carcinoma, NOS, of unknown primary site
+∞
11.5
11
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
11.5
11
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
11.5
11
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
122.1
11.5
12
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
122.1
11.5
12
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
11.2
107
538
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
10.9
198
1248
WW200, ,
SPAT
0.4
10.7
63
1348
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.5
10.6
36
106
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
111.8
10.4
11
*
Z51.0
ICD-10 Finland
Radiotherapy session
111.8
10.4
11
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
111.8
10.4
11
*
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
+∞
10.4
10
*
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
+∞
10.4
10
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
10.4
10
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
10.4
10
*
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
10.4
10
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
10.4
10
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
10.4
10
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
10.4
10
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.4
10
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.4
10
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
10.4
10
*
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
+∞
10.4
10
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
33.1
10.4
13
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
33.1
10.4
13
*
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.0
10.2
29
75
TJA10
NOMESCO Finland
Laparocentesis
55.8
9.7
11
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.5
9.6
23
52
C10AA07
ATC
rosuvastatin; oral
0.5
9.5
78
1481
Y77
ICPC
Malignant neoplasm prostate
101.5
9.4
10
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
101.5
9.4
10
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
9.4
9
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
9.4
9
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
9.4
9
*
8010/3-C80.9
ICD-O-3
Carcinoma, NOS, of unknown primary site
+∞
9.4
9
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
+∞
9.4
9
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
9.4
9
*
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
9.4
9
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
9.4
9
*
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
9.4
9
*
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
9.4
9
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
+∞
9.4
9
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
9.4
9
*
WPA13
NOMESCO Finland
Palliative consultation
22.1
9.4
13
6
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.5
9.3
32
95
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.5
9.2
31
91
R50.9
ICD-10 Finland
Fever, unspecified
2.1
9.0
96
503
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
24.4
8.9
12
5
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.6
8.9
54
222
B03XA02
ATC
darbepoetin alfa; parenteral
7.3
8.8
20
28
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.3
8.7
22
52
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.7
8.6
20
44
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
16.6
8.6
13
8
N02AA01
ATC
morphine; systemic, rectal
6.5
8.5
21
33
K56.7
ICD-10 Finland
Ileus, unspecified
4.4
8.5
21
49
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
8.5
46
1030
S77
ICPC
Malignant neoplasm of skin
91.2
8.4
9
*
JFF10
NOMESCO Finland
Loop enterostomy
91.2
8.4
9
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
91.2
8.4
9
*
D77
ICPC
Malignant digestive neopl other/NOS
91.2
8.4
9
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
91.2
8.4
9
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
91.2
8.4
9
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
91.2
8.4
9
*
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
13.0
8.4
14
11
Z31.5
ICD-10 Finland
Genetic counselling
4.1
8.4
23
58
N05AD01
ATC
haloperidol; systemic
3.1
8.4
34
112
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
+∞
8.3
8
*
L01AX03
ATC
temozolomide; systemic
+∞
8.3
8
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
8.3
8
*
8140/3-C26.9
ICD-O-3
Adenocarcinoma, NOS, of gastrointestinal tract, NOS
+∞
8.3
8
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
8.3
8
*
H01CB03
ATC
lanreotide; parenteral
+∞
8.3
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
8.3
8
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
8.3
8
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
8.3
8
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
8.3
8
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
8.3
8
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
8.3
8
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
8.3
8
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
8.3
8
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
8.3
8
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
8.3
8
*
C80.9
ICD-10 Finland
Malignant neoplasm, primary site unspecified
+∞
8.3
8
*
1952A
ICD-9 Finland
Malignant neoplasm of other and ill-defined sites, Abdomen
+∞
8.3
8
*
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
+∞
8.3
8
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
8.3
8
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.9
8.3
115
659
SPAT1109
SPAT
Analgesia with portable analgesic pump
14.7
8.2
13
9
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
22.3
8.0
11
5
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.6
8.0
46
184
J94.8
ICD-10 Finland
Other specified pleural conditions
4.7
7.9
18
39
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
7.9
134
819
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
7.8
204
1403
JMA10
NOMESCO Finland
Transabdominal total splenectomy
45.5
7.7
9
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
18.6
7.6
11
6
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
18.6
7.6
11
6
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
12.0
7.6
13
11
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
12.0
7.6
13
11
ZZR10
NOMESCO Finland
Flap of skin and muscle
25.3
7.6
10
*
Z93.3
ICD-10 Finland
Colostomy status
25.3
7.6
10
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
6.3
7.6
19
31
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
7.6
292
2206
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
81.0
7.4
8
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
81.0
7.4
8
*
H01CB02
ATC
octreotide; parenteral
81.0
7.4
8
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
7.8
7.4
16
21
J01MA12
ATC
levofloxacin; systemic
1.8
7.4
121
730
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
11.0
7.3
13
12
JFB00
NOMESCO Finland
Partial resection of small intestine
9.5
7.3
14
15
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
7.3
7
*
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
+∞
7.3
7
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
7.3
7
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
7.3
7
*
L01CB01
ATC
etoposide; systemic
+∞
7.3
7
*
JA3HT
NOMESCO Finland
Tissue sample of abdominal tissue change under UA control
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
7.3
7
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
7.3
7
*
X77
ICPC
Malignant neopl genital female other
+∞
7.3
7
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
7.3
7
*
389
Kela drug reimbursment
Olaparib
+∞
7.3
7
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
7.3
7
*
C80.91
ICD-10 Finland
Malignant tumor without specified localization epidermoid carcinoma
+∞
7.3
7
*
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
7.3
7
*
1511
Kela drug reimbursment
Olaparib
+∞
7.3
7
*
C76
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites
+∞
7.3
7
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
7.3
7
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
7.3
7
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
7.3
7
*
Z2446
NOMESCO Finland
Social worker
2.6
7.2
43
175
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.6
7.2
17
38
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
7.2
40
158
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
7.1
52
233
XW000
NOMESCO Finland
Bone marrow biopsy
3.8
7.1
21
56
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.2
7.1
13
13
H02AB09
ATC
hydrocortisone; systemic
4.3
7.0
18
43
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
7.0
49
215
R11
ICD-10 Finland
Nausea and vomiting
2.2
7.0
61
295
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.8
7.0
21
57
JFB30
NOMESCO Finland
Right hemicolectomy
14.0
6.9
11
8
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
6.9
75
395
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
40.5
6.8
8
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
40.5
6.8
8
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
40.5
6.8
8
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
22.8
6.7
9
*
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
6.6
33
123
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.2
6.6
17
41
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
8.8
6.6
13
15
A02BC02
ATC
pantoprazole; systemic
1.5
6.5
401
3322
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.0
6.5
18
46
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.0
6.5
18
46
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
70.5
6.4
7
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.8
6.4
31
114
D70.82
ICD-10 Finland
Drug-induced neutropenia
18.2
6.3
9
5
8140/3-C16.9
ICD-O-3
Adenocarcinoma, NOS, of stomach, NOS
+∞
6.3
6
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
6.3
6
*
L01XK01
ATC
olaparib; oral
+∞
6.3
6
*
C76.4
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Upper limb
+∞
6.3
6
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
6.3
6
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
6.3
6
*
8461/3-C48.2
ICD-O-3
High grade serous carcinoma of peritoneum, NOS
+∞
6.3
6
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
6.3
6
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
6.3
6
*
X76
ICPC
Malignant neoplasm breast female
+∞
6.3
6
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
6.3
6
*
L02BG03
ATC
anastrozole; oral
+∞
6.3
6
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
6.3
6
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
6.3
6
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
6.3
6
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
C26.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of digestive system
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
180
Kela drug reimbursment
Interferon alfa
+∞
6.3
6
*
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
+∞
6.3
6
*
8000/3-C76.1
ICD-O-3
Neoplasm, malignant of thorax, NOS
+∞
6.3
6
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
6.3
6
*
D48.49
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum, of unknown origin
+∞
6.3
6
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
7.1
6.2
14
20
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.5
6.2
52
997
D70.89
ICD-10 Finland
Neutropenic splenomegaly
12.7
6.1
10
8
1XC02, ,
NOMESCO Finland
12.7
6.1
10
8
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.6
6.0
16
29

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
146
110
16.83
160.56
1.5
1.2
—
—
—
0
0
206
272
10.62
156.21
4.2
1.4
87.52
2.71
ug/l
0.72
162
206
103
98
12.30
96.84
3.6
1.8
4613.10
14.04
u/ml
1.06
81
76
54
21
27.95
78.53
1.3
1.0
—
—
—
0
0
44
19
24.77
61.35
3.8
1.5
7.91
3.83
nmol/l
0.58
44
19
119
386
3.55
30.67
2.5
2.0
0.18
0.20
g/l
1.50
113
349
262
1489
2.27
21.90
5.6
3.9
—
—
—
0
0
94
332
3.14
20.76
1.5
1.1
—
—
—
0
0
34
54
6.59
20.74
1.5
1.3
1503.60
1851.03
e6/l
0.21
25
36
152
709
2.49
19.67
2.2
1.9
—
—
—
0
0
30
45
6.94
19.28
1.5
1.3
29648.12
150625.16
e6/l
0.40
16
25
248
1449
2.15
18.70
3.5
2.1
—
—
—
0
0
29
44
6.85
18.44
1.3
1.3
—
—
—
0
0
363
2457
2.08
18.39
14.7
3.6
12.65
12.20
umol/l
0.14
354
2318
25
10
25.92
18.34
1.4
3.0
—
—
—
0
0
22
7
32.45
17.13
1.5
1.4
—
—
—
0
0
23
9
26.42
17.00
1.2
1.0
—
—
—
0
0
232
1368
2.08
16.70
2.7
1.7
—
—
—
0
0
197
1108
2.12
15.95
3.3
2.0
—
—
—
0
0
25
38
6.80
15.85
1.6
1.3
—
—
—
0
0
360
2519
1.96
15.62
20.5
5.8
4.18
4.38
e9/l
0.66
311
2159
99
1954
0.42
14.64
1.9
1.9
1.51
1.30
mmol/l
1.02
82
1634
98
425
2.54
14.53
3.3
2.1
42.82
33.31
u/l
0.51
88
337
325
2238
1.90
14.38
9.0
3.7
32.42
35.23
g/l
11.91
315
2063
377
4710
0.52
13.91
4.9
6.3
2.53
2.56
mmol/l
0.22
329
4296
241
1537
1.90
13.21
6.3
5.0
—
—
—
0
0
368
4598
0.54
12.90
4.4
5.4
4.42
4.46
mmol/l
0.37
326
4205
364
4556
0.54
12.70
4.3
5.3
1.43
1.46
mmol/l
0.76
319
4137
301
2081
1.83
12.63
3.8
2.4
—
—
estimate
—
0
0
363
4541
0.55
12.53
6.9
7.2
40.50
40.31
mmol/mol
0.14
326
4197
24
45
5.50
12.38
1.5
1.3
—
—
—
0
0
377
4655
0.55
12.23
5.4
5.5
6.09
6.07
mmol/l
0.11
336
4182
348
4370
0.56
11.54
4.0
4.5
1.33
1.26
mmol/l
1.01
296
3918
20
35
5.86
11.06
1.4
1.3
—
—
—
0
0
432
5077
0.56
10.63
51.2
23.4
258.19
242.05
e9/l
3.33
426
4940
432
5077
0.56
10.63
51.1
23.3
30.14
30.41
pg
2.01
427
4991
432
5077
0.56
10.63
52.3
23.7
37.14
39.84
%
23.89
427
4987
432
5077
0.56
10.63
51.3
23.3
4.13
4.42
e12/l
20.94
421
4920
300
2149
1.74
10.57
7.4
5.3
9.23
8.95
%
0.76
284
1994
432
5074
0.56
10.54
51.2
23.3
91.56
91.58
fl
0.03
427
4988
433
5078
0.56
10.40
51.3
23.4
7.14
6.86
e9/l
1.28
423
4922
298
2157
1.70
9.92
7.3
5.3
0.61
0.66
%
0.71
282
1998
297
2151
1.70
9.84
7.3
5.2
2.28
2.95
%
5.31
282
1999
299
2185
1.68
9.47
7.4
5.3
23.57
26.28
%
3.56
286
2054
294
2144
1.68
9.35
7.1
5.3
61.43
58.48
%
3.31
281
2033
98
510
2.09
9.32
2.8
2.1
14.01
7.81
umol/l
1.30
88
437
121
680
1.96
9.30
6.4
4.2
1.09
1.02
mmol/l
1.27
116
617
20
42
4.88
9.11
1.8
1.8
83.70
24.62
ng/l
0.74
20
42
227
1554
1.71
9.09
6.3
3.0
7.40
7.40
ph
0.16
165
1118
52
208
2.63
9.04
1.9
1.6
3.17
1.87
ug/l
0.27
45
178
334
2545
1.64
8.76
14.6
19.1
1.25
1.37
inr
3.76
276
2161
432
5006
0.59
8.61
45.1
21.0
86.44
82.06
umol/l
0.69
427
4921
313
2355
1.63
8.57
7.2
5.2
0.60
0.60
e9/l
0.03
262
1989
313
2365
1.62
8.36
7.2
5.2
0.04
0.04
e9/l
0.36
262
2006
114
650
1.91
8.35
7.2
6.0
0.82
1.15
mmol/l
0.35
101
532
314
2379
1.62
8.26
9.8
5.2
1.20
1.21
mmol/l
0.67
299
2145
371
4445
0.61
8.23
6.0
5.3
2.05
1.99
mu/l
0.29
328
4023
114
657
1.89
8.07
7.2
6.0
7.42
7.42
ph
0.43
58
396
225
1578
1.65
8.02
3.8
2.2
56.18
61.41
u/l
0.57
211
1454
82
423
2.07
7.96
1.8
1.4
—
—
—
0
0
314
2396
1.60
7.90
7.3
5.2
1.51
1.81
e9/l
7.13
267
2074
53
229
2.43
7.86
1.5
1.3
—
—
—
0
0
317
2435
1.59
7.69
7.5
5.2
0.16
0.20
e9/l
3.91
271
2089
427
4920
0.61
7.55
22.8
10.3
29.11
24.45
u/l
1.59
416
4716
428
4927
0.62
7.50
41.1
19.8
3.99
4.01
mmol/l
0.65
421
4804
126
766
1.80
7.49
2.9
2.3
21.32
22.24
%
0.31
115
707
428
4921
0.62
7.36
41.2
19.7
138.54
139.73
mmol/l
13.47
422
4808
73
375
2.07
7.16
1.9
1.4
—
—
—
0
0
72
373
2.05
6.90
5.1
3.7
1.50
0.84
%
1.20
32
88
238
1744
1.58
6.86
8.2
2.1
2.34
2.35
mmol/l
0.66
231
1509
12
11
11.09
6.82
1.0
1.1
22.08
12.77
g/l
—
12
6
337
2673
1.54
6.79
11.7
5.6
1.21
1.21
mmol/l
0.55
296
2299
417
4794
0.64
6.71
27.3
14.5
—
—
—
0
0
17
42
4.13
6.39
1.1
1.2
—
—
—
0
0
100
1579
0.57
6.38
3.1
3.6
—
—
—
0
0
130
836
1.69
6.28
2.9
2.3
2.06
2.24
g/l
2.97
119
768
154
1046
1.62
5.99
1.7
1.6
2.31
1.25
mg/l
1.48
133
821
14
22
6.48
5.88
8.0
1.1
14.44
29.00
u/ml
—
5
6
125
820
1.65
5.56
4.0
3.1
2.89
2.77
e6/l
0.05
67
401
17
47
3.69
5.51
5.4
2.3
11.96
6688.45
u/l
—
5
14
5
0
+∞
5.21
12.0
0.0
0.26
—
umol/l
—
5
0
134
910
1.60
5.16
3.1
2.3
10.76
12.32
umol/l
1.79
123
835
84
505
1.76
5.13
1.9
1.6
—
—
—
0
0
147
1032
1.55
4.88
4.0
2.9
535.19
527.14
mosm/kgh2o
0.18
126
904
27
107
2.59
4.85
2.0
1.8
36.59
31.83
umol/l
0.36
22
95
12
21
5.80
4.77
1.2
1.0
—
—
—
0
0
77
463
1.75
4.70
10.3
6.4
—
—
—
0
0
224
1730
1.45
4.64
3.9
3.5
—
—
—
0
0
63
359
1.84
4.60
5.4
3.8
0.30
0.04
%
0.78
23
73
63
359
1.84
4.60
5.5
3.7
1.10
0.67
%
0.67
29
91
192
1446
1.47
4.51
4.7
3.2
0.40
0.47
e6/l
0.38
147
1074
317
3723
0.71
4.44
5.2
4.1
15.22
15.03
pmol/l
0.64
280
3343
11
20
5.57
4.30
1.1
1.2
—
—
—
0
0
9
13
7.00
4.17
1.6
1.0
—
—
—
0
0
194
1485
1.44
4.14
5.3
2.6
36.16
35.60
u/l
0.06
185
1395
63
372
1.77
4.11
5.8
4.0
3.62
0.01
%
0.51
24
72
12
26
4.68
4.07
1.1
1.3
7.41
7.41
ph
—
6
17
31
147
2.16
3.81
2.2
1.3
1.38
1.40
ratio
0.05
19
94
168
1279
1.42
3.63
3.7
2.5
360.26
358.16
umol/l
0.08
142
1083
6
6
10.08
3.50
1.0
1.0
—
—
—
0
0
144
1877
0.70
3.47
3.4
3.4
92.66
44.67
mg/l
1.31
98
1201
22
94
2.39
3.44
1.5
1.2
—
—
—
0
0
85
571
1.56
3.40
1.9
1.7
—
—
—
0
0
34
177
1.97
3.30
2.9
2.4
297.65
270.34
mg/l
0.10
17
58
13
43
3.06
3.26
2.2
1.1
—
—
—
0
0
427
4688
0.74
3.20
34.0
15.6
37.60
25.87
mg/l
10.23
401
3877
32
165
1.99
3.20
4.6
1.7
—
—
—
0
0
151
1930
0.72
3.19
3.3
3.3
7.30
7.09
mmol/l
0.24
129
1620
151
1930
0.72
3.19
3.9
4.0
15.67
7.94
mg/mmol
0.80
100
1207
16
61
2.66
3.15
1.3
1.2
—
—
—
0
0
211
1706
1.35
3.11
4.8
3.3
61.48
115.73
e6/l
0.60
167
1324
210
2537
0.75
3.04
2.1
2.2
97.40
94.68
pmol/l
0.31
116
1278
12
37
3.28
2.94
3.4
2.9
—
—
—
0
0
56
353
1.64
2.93
5.3
4.2
—
—
—
0
0
172
1364
1.35
2.85
17.3
4.5
—
—
—
0
0
247
2069
1.31
2.80
17.7
9.6
0.01
0.00
e9/l
0.75
194
1681
144
1113
1.38
2.80
1.4
1.3
—
—
—
0
0
24
452
0.51
2.71
1.7
1.6
—
—
—
0
0
40
241
1.70
2.50
1.8
1.5
1.92
1.59
g/l
0.89
35
213
73
1019
0.68
2.49
1.2
1.3
1.05
1.29
u/ml
0.19
15
274
14
57
2.49
2.46
1.6
2.6
—
—
—
0
0
43
267
1.65
2.42
6.0
4.0
36.95
36.89
°c
0.49
43
260
226
1901
1.29
2.42
5.9
4.0
57.65
122.30
e6/l
2.03
169
1360
406
3676
1.28
2.37
17.0
5.4
110.46
78.43
u/l
5.99
392
3396
33
192
1.76
2.34
5.2
4.2
25.22
25.06
mmol/l
0.09
33
175
151
1209
1.32
2.31
3.7
2.6
5.64
5.54
e6/l
0.03
139
1104
25
134
1.90
2.29
1.4
1.4
148.47
312.62
ug/g
5.92
15
80
7
18
3.92
2.25
1.0
1.1
—
—
—
0
0
342
3048
1.26
2.22
6.8
4.4
6.94
6.82
mmol/l
0.56
331
2899
90
669
1.40
2.21
2.2
1.9
1.99
1.76
%
1.04
81
592
22
116
1.93
2.13
3.6
3.9
1.52
1.72
mg/l
0.42
22
97
20
102
1.99
2.12
3.3
3.8
—
—
—
0
0
71
965
0.70
2.10
3.1
2.9
0.65
0.82
ug/l
1.43
50
650
176
1457
1.29
2.09
2.2
2.3
3.19
2.83
mg/l
1.08
146
1238
13
56
2.35
2.06
1.1
1.0
—
—
—
0
0
143
1739
0.77
2.00
1.7
1.7
17.99
20.05
nmol/l
0.91
125
1461
53
365
1.49
1.96
4.1
3.8
5.14
5.21
kpa
0.24
53
346
5
142
0.35
1.89
1.4
1.7
—
—
—
0
0
12
52
2.33
1.88
1.2
1.4
—
—
—
0
0
12
52
2.33
1.88
1.2
1.4
—
—
—
0
0
12
52
2.33
1.88
1.2
1.4
—
—
—
0
0
12
52
2.33
1.88
1.2
1.4
—
—
—
0
0
52
360
1.48
1.88
4.1
3.8
7.43
7.41
ph
1.20
46
294
69
513
1.39
1.72
2.2
1.8
68.49
67.66
e9/l
0.06
47
386
145
1728
0.79
1.69
5.9
4.3
4.55
2.19
ug/l
1.34
129
1519
59
796
0.72
1.68
1.2
1.3
38.32
12.85
u/ml
0.81
23
293
6
19
3.18
1.66
1.0
1.0
—
—
—
0
0
9
187
0.47
1.64
1.0
1.1
—
—
—
0
0
64
846
0.73
1.61
1.3
1.3
111.72
32.93
iu/ml
0.64
17
259
6
20
3.02
1.58
1.2
1.5
140.00
163.18
mmol/24h
—
6
20
6
21
2.87
1.51
2.2
1.6
0.32
0.96
e9/l
—
6
21
6
21
2.87
1.51
2.0
2.1
33.23
48.31
%
—
6
21
15
79
1.92
1.50
1.4
1.2
—
—
—
0
0
66
501
1.35
1.47
7.4
3.7
7.38
7.36
ph
0.79
54
329
40
279
1.46
1.44
2.6
2.3
9.03
14.72
nmol/l
3.53
35
254
5
16
3.14
1.44
1.4
1.8
47.00
180.63
e6/l
—
5
16
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
38
263
1.47
1.42
4.7
3.9
—
—
—
0
0
83
656
1.30
1.42
1.2
1.2
—
—
—
0
0
359
3308
1.19
1.41
6.6
5.0
488.00
3006.12
e6/l
—
5
65
23
142
1.64
1.40
1.1
1.1
—
—
—
0
0
104
1254
0.80
1.33
5.8
4.3
1.02
1.02
kg/l
0.90
75
837
30
202
1.51
1.29
5.1
3.7
1.29
1.45
mmol/l
0.39
30
196
77
611
1.30
1.29
5.3
3.1
7.37
7.38
ph
0.58
46
381
115
959
1.24
1.28
6.9
4.1
—
—
—
0
0
6
135
0.44
1.28
1.2
1.1
—
—
—
0
0
202
2269
0.84
1.26
2.4
2.4
74.70
79.67
nmol/l
1.90
181
1996
21
131
1.62
1.25
3.7
3.5
1.10
1.21
index
—
10
62
75
597
1.29
1.23
5.3
3.0
1.79
2.07
mmol/l
0.26
67
517
12
64
1.89
1.18
1.1
1.0
—
—
—
0
0
6
129
0.46
1.17
1.0
1.1
—
—
—
0
0
6
129
0.46
1.17
3.0
1.9
39.67
40.89
nmol/l
—
6
122
177
1997
0.84
1.14
6.5
4.1
0.00
0.02
estimate
1.05
56
415
0
36
0.00
1.14
0.0
1.0
—
0.57
—
0
11
9
46
1.97
1.04
1.2
1.3
—
—
—
0
0
17
262
0.64
1.02
1.2
1.4
—
—
—
0
0
7
35
2.01
1.00
1.4
1.1
—
—
—
0
0
5
23
2.18
0.98
1.8
1.7
252.60
564.83
e6/l
—
5
18
68
557
1.25
0.92
2.2
2.5
3.51
6.88
ug/l
2.54
58
483
16
243
0.65
0.92
1.2
1.4
—
—
—
0
0
25
344
0.72
0.87
1.2
1.2
—
—
—
0
0
8
45
1.79
0.84
1.1
1.1
—
—
—
0
0
56
457
1.25
0.80
1.3
1.3
—
—
—
0
0
10
58
1.74
0.80
1.3
1.6
276.20
271.34
mosm/kgh2o
—
5
41
0
27
0.00
0.77
0.0
2.1
—
95.33
—
0
21
0
27
0.00
0.77
0.0
1.3
—
—
—
0
0
39
307
1.29
0.75
4.7
2.3
0.66
0.61
%
0.57
39
307
7
38
1.85
0.73
2.3
2.3
—
—
—
0
0
11
68
1.63
0.72
2.2
1.7
1.69
0.94
g/l
—
6
56
12
182
0.65
0.71
10.0
10.1
—
—
—
0
0
66
557
1.21
0.71
5.1
2.8
4.42
4.90
e9/l
0.47
61
464
39
481
0.80
0.66
2.5
2.0
0.00
0.00
estimate
—
6
96
29
224
1.31
0.66
1.3
1.3
—
—
—
0
0
20
270
0.73
0.65
2.6
2.0
—
—
—
0
0
7
44
1.60
0.65
2.0
2.5
—
—
—
0
0
15
104
1.45
0.63
5.5
3.8
3.54
2.98
mmol/l
—
10
66
126
1393
0.88
0.61
6.0
3.6
0.04
0.00
estimate
0.45
51
400
128
1156
1.13
0.61
4.2
4.5
27.25
371.79
ng/l
5.77
103
980
11
72
1.54
0.59
1.1
1.1
26.99
20.73
u/l
0.24
11
61
38
311
1.24
0.57
4.9
2.4
1.10
1.12
%
0.05
38
311
11
73
1.52
0.56
1.4
1.3
69.07
79.16
mu/l
0.07
11
66
27
212
1.29
0.56
1.1
1.7
—
13.45
—
0
6
10
65
1.55
0.55
1.1
1.2
—
—
nmol/l
—
0
0
198
2119
0.91
0.54
5.3
3.7
6.27
6.27
ph
0.00
105
1183
166
1790
0.90
0.53
2.1
2.2
147.37
257.15
u/l
1.45
158
1684
248
2620
0.91
0.52
6.0
4.1
0.00
0.00
estimate
-0.00
64
531
278
2919
0.92
0.50
4.6
3.1
81.44
47.89
u/l
3.61
255
2700
138
1497
0.90
0.49
6.3
4.0
0.00
0.00
estimate
-0.00
61
482
12
84
1.44
0.49
1.0
1.2
—
—
—
0
0
76
853
0.88
0.48
1.4
1.3
2.88
2.67
g/l
0.25
50
496
34
408
0.82
0.48
3.6
2.8
5.87
6.07
ph
1.00
26
285
7
47
1.49
0.47
1.3
1.5
7.97
10.70
%
—
7
47
12
164
0.73
0.45
3.0
3.7
0.80
0.84
nmol/l
—
7
135
36
302
1.20
0.45
3.6
2.8
24.50
25.42
mmol/l
1.01
36
290
253
2657
0.92
0.45
5.9
4.1
0.00
0.00
estimate
-0.00
65
549
213
2253
0.92
0.45
4.5
4.3
39.42
85.96
ng/l
0.95
184
1724
105
1148
0.90
0.44
1.9
1.8
1300.22
1166.80
nmol/l
0.60
85
870
255
2675
0.92
0.44
5.9
4.1
0.00
0.02
estimate
1.34
64
524
10
70
1.44
0.42
5.9
2.5
4.24
4.59
e9/l
—
10
70
0
18
0.00
0.40
0.0
12.6
—
0.63
—
0
18
8
61
1.32
0.39
1.6
2.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
62.14
—
0
14
9
68
1.33
0.37
1.8
1.4
—
—
—
0
0
10
72
1.39
0.37
1.4
1.4
1.00
0.85
%
—
5
52
40
348
1.16
0.35
8.0
3.7
—
—
—
0
0
14
108
1.30
0.35
1.3
1.4
—
—
—
0
0
6
43
1.40
0.35
3.5
1.6
9.45
7.97
mmol/l
—
6
43
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
6
43
1.40
0.35
4.2
1.5
15.00
16.37
%
—
6
43
23
192
1.21
0.32
1.3
1.2
—
—
—
0
0
13
164
0.79
0.31
1.6
1.5
19.50
16.18
u/ml
—
6
23
10
75
1.34
0.30
1.6
1.2
2.26
25.69
nmol/l
—
10
68
11
84
1.31
0.30
1.3
1.7
302.64
279.66
mu/l
0.08
11
77
11
85
1.30
0.28
3.6
1.1
—
—
—
0
0
31
272
1.15
0.26
2.5
2.5
—
—
—
0
0
10
77
1.30
0.26
1.0
1.1
—
—
—
0
0
22
189
1.17
0.24
1.0
1.3
—
—
—
0
0
5
38
1.32
0.23
4.0
1.1
—
—
—
0
0
5
39
1.28
0.23
1.4
1.1
138.40
100.31
pmol/l
—
5
39
24
210
1.15
0.22
1.4
1.5
—
—
—
0
0
25
283
0.88
0.21
1.2
1.2
113.15
314.47
u/ml
1.79
19
260
5
42
1.19
0.21
5.8
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
209.80
—
0
5
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
5
43
1.16
0.21
2.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
6.6
—
8.24
—
0
14
6
49
1.23
0.20
1.2
1.2
—
—
—
0
0
7
60
1.17
0.18
2.4
1.9
—
—
—
0
0
16
138
1.16
0.17
1.9
2.2
126.00
131.02
g/l
0.35
11
110
7
63
1.11
0.17
2.0
2.8
—
—
—
0
0
122
1269
0.95
0.17
1.8
1.8
523.72
4826701.03
pmol/l
0.50
92
1036
9
83
1.09
0.14
1.8
1.4
—
—
—
0
0
10
84
1.19
0.14
1.7
1.4
—
—
—
0
0
10
84
1.19
0.14
1.7
1.4
—
—
—
0
0
10
84
1.19
0.14
1.7
1.4
—
—
—
0
0
60
632
0.94
0.13
1.3
1.4
536.00
589.37
titre
—
10
158
223
2190
1.03
0.11
3.3
2.9
215.70
123.97
ug/l
4.46
206
2005
59
565
1.05
0.10
1.7
1.5
—
—
—
0
0
5
45
1.11
0.10
1.8
1.5
—
—
—
0
0
31
330
0.94
0.09
1.1
1.3
—
—
—
0
0
36
381
0.94
0.09
1.7
1.5
—
—
—
0
0
10
87
1.15
0.09
6.2
2.3
62.90
59.51
%
—
10
87
6
57
1.05
0.08
2.2
1.7
81.22
90.29
%
—
6
57
6
72
0.83
0.07
2.0
2.5
—
—
—
0
0
9
84
1.07
0.07
1.8
1.4
—
—
—
0
0
50
518
0.96
0.06
1.7
2.2
197.11
151.17
ug/g
0.38
41
404
16
148
1.08
0.06
1.4
1.5
1.28
1.14
g/l
1.17
16
141
11
100
1.10
0.05
3.5
1.2
3.94
3.86
mmol/l
0.09
11
94
14
130
1.08
0.04
2.7
2.4
154.00
82.11
ug/min
—
7
79
196
1943
1.01
0.03
3.5
3.3
1453.73
1731.13
ng/l
0.44
179
1676
10
104
0.96
0.00
4.0
1.3
58.10
1262.92
e6/l
—
10
86
17
165
1.03
0.00
3.6
2.9
1.59
1.53
mmol/l
0.06
17
160
11
114
0.96
0.00
3.7
1.3
364.82
522.49
mg/l
1.35
11
108
10
103
0.97
0.00
4.0
1.2
17.70
60.61
e6/l
—
10
84
13
133
0.98
0.00
1.2
1.1
—
—
—
0
0
52
522
1.00
0.00
2.7
3.5
190.50
276.11
ng/l
1.03
46
485
342
3425
1.00
0.00
6.3
4.7
—
3.43
—
0
6
15
150
1.00
-0.00
4.3
5.0
—
—
—
0
0
14
140
1.00
-0.00
8.4
2.1
60.04
61.21
%
0.06
14
135
0
9
0.00
-0.00
0.0
1.1
—
40.87
—
0
9
8
86
0.93
-0.00
1.5
2.5
3.77
4.11
mmol/l
—
8
86
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0
7
73
0.96
-0.00
3.1
6.3
6.64
7.30
mmol/l
—
7
63
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.02
—
0
5
0
8
0.00
-0.00
0.0
1.5
—
67.38
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
36.57
—
0
7
0
8
0.00
-0.00
0.0
2.1
—
0.56
—
0
8
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
64.00
—
0
6
8
86
0.93
-0.00
1.5
2.5
107.75
105.29
mmol/l
—
8
86
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
74
0.95
-0.00
1.4
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.1
—
0.00
—
0
8
8
84
0.95
-0.00
1.5
2.5
1.19
1.19
mmol/l
—
8
84
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

Index endpoint: C3_OTHER_OR_ILLDEFINED_SITES_WIDE – Malignant neoplasm of other and ill-defined sites, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).